先看重點
在NHANES 2007-2018年的893名50歲及以上絕經後女性中,較高的系統免疫炎症指數(SII)與股骨總體和股骨頸骨密度較低、骨量低或骨質疏鬆的風險較高相關。這種橫斷面關聯不能說明炎症導致骨丟失,摘要也未給出效應量。
證據類型
橫斷面研究
解讀依據
公開摘要
閱讀重點
關聯與混雜
研究在問什麼
慢性炎症被認為會加速骨丟失,而系統免疫炎症指數是一個由血細胞計數算出的簡單比值,可能有助於提示風險。作者檢驗了SII及若干相關血液指標與絕經後女性骨密度(BMD)以及骨量減少或骨質疏鬆的關係。
研究對象與方法
這是對美國國家健康與營養調查(NHANES)2007-2018年中50歲及以上絕經後女性的橫斷面分析。骨密度用雙能X線吸收法測量。SII由淋巴細胞、中性粒細胞和血小板計數計算,其他指標包括血小板與淋巴細胞比值、中性粒細胞與淋巴細胞比值(NLR)、血小板與中性粒細胞計數之積(PPN)及各細胞計數。研究用多變數加權線性迴歸分析骨密度,用加權Logistic迴歸分析低骨密度或骨質疏鬆。共納入893名女性(加權平均年齡60.90 ± 0.26歲)。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1較高的SII與股骨總體和股骨頸骨密度呈負相關,SII較高四分位組女性的腰椎骨密度低於最低四分位組。
- 2較高的SII與低骨密度和骨質疏鬆的風險升高相關。NLR和PPN也與骨密度呈負相關、與骨質疏鬆風險呈正相關。
- 3亞組分析顯示,骨密度與炎症指標的關聯在≥65歲或BMI正常(<25 kg/m2)的女性中更明顯。
限制與不確定性
- 1橫斷面資料無法說明是炎症先於骨丟失還是相反,單次血細胞計數也可能受急性疾病或藥物影響。
- 2僅納入893名女性,按年齡和BMI分層的亞組結果屬於探索性。
- 3作者承認研究存在侷限,並呼籲開展更大規模的研究;摘要沒有給出效應量或置信區間。以上解讀僅基於摘要。
日常健康啟示
SII偏高可能是絕經後女性骨丟失風險較高的又一個訊號,但它不是診斷檢查。骨密度需要透過DXA檢查,所以有擔憂的女性應與醫師討論骨骼健康和篩查,而不是隻看一次血常規。
如何連結自己的資料
SII來自常規化驗的血細胞計數(淋巴細胞、中性粒細胞和血小板),不是穿戴式裝置資料。如果你儲存化驗結果,請比較同一家檢驗機構多年的資料並關注趨勢,骨骼本身要靠掃描來評估。
如何理解這類證據
同一時期的測量通常不能確定方向或因果;症狀可能改變行為,不能只按行為導致症狀解釋。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
This study aimed to investigate the association between the systemic immune-inflammation index (SII) and bone mineral density (BMD) and to determine the association between the SII and the risk of osteopenia/osteoporosis among postmenopausal women aged ≥50 years.
Methods
Postmenopausal women aged ≥50 years from the National Health and Nutrition Examination Survey were included. BMD testing was performed using dual-energy X-ray absorptiometry. The SII was calculated based on lymphocyte (LC), neutrophil (NC), and platelet (PC) counts. Moreover, the associations of BMD with SII and other inflammatory markers, including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), the product of platelet count and neutrophil count (PPN), PC, NC, and LC, were assessed using a multivariable weighted linear regression model. Additionally, the associations of low BMD/osteoporosis with SII and other inflammatory markers were assessed using multivariable weighted logistic regression.
Results
Finally, a total of 893 postmenopausal women with a weighted mean age of 60.90 ± 0.26 years were included finally. This study found that SII was negatively associated with total femur BMD and femoral neck BMD, and postmenopausal women in a higher SII quarter group showed low lumbar spine BMD than the lowest SII quarter group when SII was converted from a continuous variable to a categorical variable. Moreover, increased SII was associated with an increased risk of low BMD and osteoporosis. In addition, this study observed that other inflammatory markers, especially NLR and PPN, were negatively associated with BMD and positively associated with the risk of osteoporosis. Finally, the subgroup analysis showed that the associations between BMD and inflammatory markers were pronounced in postmenopausal women aged ≥65 years or those with normal BMI (<25 kg/m^(2)).
Conclusion
SII may be a valuable and convenient inflammatory marker that could be applied to predict the risk of low BMD or osteoporosis among postmenopausal women aged ≥50. Moreover, postmenopausal women with a high level of SII or other inflammatory markers, such as NLR and PPN, should be aware of the potential risk of osteoporosis. However, given the inherent limitations of the present study, additional large-scale studies are required to investigate the role of SII in osteoporosis further.
來源與署名
Systemic immune-inflammation index and bone mineral density in postmenopausal women: A cross-sectional study of the national health and nutrition examination survey (NHANES) 2007-2018.
Tang Y, Peng B, Liu J, Liu Z, Xia Y, Geng B.
Frontiers in immunology · 2022-09-08
DOI: 10.3389/fimmu.2022.975400 ↗PubMed · 36159805 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
更早的進食視窗與更大的體重和胰島素獲益相關,優於晚間進食
彙總41項隨機對照試驗(2287名參與者,介入時間中位數8週)發現,限時進食比日常飲食體重低2.15 kg(95%置信區間−2.56至−1.74),而早吃比晚吃體重多降1.15 kg(95%置信區間−1.86至−0.45)。多數試驗較短,只有6個研究組檢驗了早間進食,結局是身體和血液指標,不是心臟病發作或死亡。
BMJ Medicine
限熱量飲食再加上午8點至下午4點進食視窗,1年減重無明顯額外優勢
139名肥胖患者都按限制熱量的飲食進食,其中一組再加上上午8:00至下午4:00的進食視窗,12個月平均體重變化為−8.0 kg,單純限熱量組為−6.3 kg。淨差值−1.8 kg(95%置信區間−4.0至0.4;P=0.11)無統計學意義,該區間既不能排除視窗確有獲益,也不能排除毫無作用。
The New England Journal of Medicine
20人住院試驗:超加工飲食讓人每天多攝取508 kcal並增重
20名成年人在醫院研究病房住了28天,兩種選單各吃2週、想吃多少吃多少:超加工選單讓他們每天多攝取508 kcal(±106,標準誤,P=0.0001),體重增加0.9 kg;未加工選單則讓體重減輕0.9 kg。樣本小、週期短、食物全程由研究方提供,既不能說明日常生活中的長期結果,也無法確定是食物的哪種特點導致多吃。
Cell Metabolism
地中海飲食加橄欖油或堅果與心血管事件減少相關(更正後的試驗)
在7447名55至80歲、心血管風險較高的西班牙成年人中,被分到加特級初榨橄欖油(風險比0.69,95%置信區間0.53至0.91)或加堅果(風險比0.72,0.54至0.95)的地中海飲食組,發生主要心血管事件的風險低於被告知減少脂肪的對照組。試驗存在隨機化失誤,2013年的報告已撤回並重新估算,證據有力但並不完美。
The New England Journal of Medicine

